A randomized trial of methotrexate versus azathioprine for severe atopic eczema
- 1 August 2011
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 128 (2) , 353-359
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Off-label Use of Azathioprine in DermatologyArchives of Dermatology, 2011
- Prednisolone vs. ciclosporin for severe adult eczema. An investigator-initiated double-blind placebo-controlled multicentre trialBritish Journal of Dermatology, 2009
- Psychiatric comorbidity in adult eczemaBritish Journal of Dermatology, 2009
- Diagnostic criteria for atopic dermatitis: a systematic reviewBritish Journal of Dermatology, 2008
- An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczemaBritish Journal of Dermatology, 2007
- Systemic Treatment of Severe Atopic Eczema: A Systematic ReviewActa Dermato-Venereologica, 2007
- Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trialThe Lancet, 2006
- Experience with low-dose methotrexate for the treatment of eczema in the elderlyJournal of the American Academy of Dermatology, 2003
- Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trialBritish Journal of Dermatology, 2002
- Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhoodJournal of Allergy and Clinical Immunology, 1999